Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2
Pancreatitis , although instances are rare with this medication, patients should be vigilant for symptoms such as severe abdominal pain that may radiate to the back, nausea, or vomiting
Results of a new review suggested that GLP-1 agonists may serve as a safe adjunctive therapy for smoking cessation, especially in patients who are more prone to relapsing due to weight gain, such as women and obese patients
WIth standard dosing, the initial 3 months of therapy vary in effectiveness and side effect rate for patients
For the last year or two, Id been battling what I can only describe as low-grade brain fog
Le dosi variano da 400-1.000 mg al giorno